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Background: Geographical variation in lupus nephritis epidemiology may indicate important environmental factors
contributions to the etiology of lupus nephritis. This paper first describes the epidemiology of biopsy-proven lupus
nephritis in China by performing a systematic literature review and the possible social-environmental influential
factors.
Methods: The keywords “lupus nephritis”, “renal biopsy” and “systemic lupus erythematous” were searched in the
three largest Chinese electronic databases and Medline/PubMed. The data of the patients with biopsy-proven lupus
nephritis were extracted. The possible environmental influential factors including the population density, ethnic
group populations, the ratio of females to males, the average sunshine per year, annual average temperature and
annual relative humidity, in different regions of China were analyzed.
Results: Forty-one study centers with 34574 renal disease patients, and 3699 lupus nephritis patients met the
inclusion criteria. Lupus nephritis accounts for 2.37% to 25% of all renal disease and 27.2% to 80.65% of renal
disease associated with secondary glomerular diseases. The male-to-female ratio is approximately 1:5 in lupus
nephritis patients. The included period is predominantly from 1995 to 2010. The proportion ratio of biopsy-proven
lupus nephritis in all renal disease or in secondary glomerular disease significantly increased with decreasing latitude
from the north to the south part of China. The population is predominantly Han Chinese.
Conclusions: Geographical distribution appears to be a risk factor for the incidence of biopsy-proven LN in China.
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Environmental and genetic factors interact to result in
the development of systemic lupus erythematous (SLE)
[1]. Many epidemiologic studies of SLE have been un-
dertaken worldwide [2,3] and have detailed worldwide
SLE epidemiology, considering the effects of gender, race,
and age on presentation and mortality [4,5].
Renal involvement is common in SLE patients, although
accurate current data and systematic investigation of the
epidemiology of lupus nephritis (LN) worldwide are
largely lacking [6]. The epidemiology of LN based on
a selected population and the diagnostic criteria for de-
fining SLE was reported [7]. The LN cumulative incidence
is lower in Caucasians (14%) with SLE compared with
Asians (55%), African lineages (51%) and Hispanics (43%)* Correspondence: hf-liu@263.net
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unless otherwise stated.with SLE [8,9]. LN is associated with more severe renal in-
volvement in the patients from African lineage, Hispanics
and Asian populations [9-14]. Also, LN is more likely to
be associated with severe nephritis in children and less
likely to be associated with severe neuritis in the elderly
[15].
These reviews included very few studies conducted in
China. There is no systematic investigation of the epi-
demiology of LN in China. Reports of the incidence of
biopsy-proven LN in different geographical regions of
China have yielded different results, possibly because the
vast territory and a huge population of China results in
marked differences in environmental and genetic risk
factors for LN. Research papers published in Chinese or
other languages are yet to be reviewed to determine the
epidemiology of biopsy-proven LN in China.
In this study, we examined the association between
geographic distribution and the epidemiology of biopsy-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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disease published in different parts of China. We found
that LN may be more prevalent in southern China.Methods
Search strategy: “Lupus nephritis”, “renal biopsy” and “sys-
temic lupus erythematous” were the key words searched
in the three largest Chinese electronic databases inclu-
ding the China National Knowledge Infrastructure (CNKI,
www.cnki.net, inception 1994), Wan Fang (www.wanfang
data.com.cn, inception 1982), and Vi Pu (www.cqvip.com,
inception 1989) The identical keywords with “Chinese”
and “China” were searched in the database of Medline/
PubMed for papers published from the inception of the
databases to July 2013. The data of the patients with lupus
nephritis diagnosed by renal biopsy were extracted and
analyzed. The geographical distributions of the cities in
which the study centers were located were found with
Google Maps. We reviewed each paper with inclusion and
exclusion criteria.
Inclusion and exclusion criteria: The inclusion criteria
for the analyzed papers are as follows: (1) the location of
the study centers are in mainland China; (2) the number
of patients with biopsy-proven renal diseases was more
than 100 cases in each paper; (3) the define of LN was
by renal biopsy. (4) The diagnostic criteria for the stu-
dies are as follows: the classification of each patient's
pathological histological type of renal disease was ac-
cording to the WHO criteria for the histological classifi-
cation of glomerular defined in 1982 [16] and revised in
1995 [17] and the criteria of the ISN/RPS. The exclusion
criteria for this study are papers that do not meet any
items of (1), (2), (3) and (4).
Data Analysis: The characteristics of the analyzed
studies included the geographical distribution of the stu-
dy centers, the research period, and the ratio of the
number of females to males for all of the renal biopsies
or the LN group, if provided. Pearson's correlation co-
efficients were calculated to assess the linear associ-
ation between the proportions of the biopsy-proven
LN in all renal diseases or in secondary glomerular
diseases (SGD) and the geographical distribution of the
study centers. The calculations were performed with SPSS
(14.0) software, and statistical significance was established
at p < 0.05.
The possible influential factors: To investigate the
possible factors that are influential on geographical
variation in the epidemiology of biopsy-proven lupus
nephritis in China, we investigated the population den-
sity, ethnic group populations, the ratio of females to
males, the average sunshine per year, annual average
trmperature and annual relative humidity in different
regions of China.Results
The characteristics of the study centers included in the
analyses
Our literature searches yielded 41 studies that met the
study validation criteria (Table 1) [18-58], which all ori-
ginate from the Chinese databases. All of the selected
studies were retrospective and included 34574 biopsy-
proven renal disease patients and 3699 biopsy-proven
LN patients. The World Health Organization 1995 Clas-
sification System (issued in 1982) is the most commonly
used criteria for patients who had a renal biopsy. The study
centers were normally distributed in China (Figure 1A)
and most of the study period was from 1995 to 2010
(Figure 1B).
Based on the forty-one studies, LN was the most com-
mon SGD found by percutaneous kidney biopsy and
accounted for 2.37% to 25% of all biopsy-proven renal
diseases and 27.2% to 80.65% of renal disease biopsies
performed for secondary causes of glomerular disease.
The ratio of male-to-female in the biopsy-proven LN
patients was approximately 1:5 based on the provided
data (Figure 1D) [20,27,36,49,54,58]. and approximately
1:1 in all biopsy-proven renal diseases (Figure 1C)
[18-58].
The correlation between the geographical distribution
and the proportion of biopsy-proven LN
The proportion of biopsy-proven LN in all biopsy-
proven renal diseases (r = 0.524; P < 0.001) (Figure 2A)
and in secondary glomerular diseases (SGD) (r = 0.460;
P < 0.001) (Figure 2B) significantly increased in response
to the decreasing geographic latitude from the northern
part to the southern part of China, but there was no sig-
nificant correlation with the change in the geographic
longitude (all P > 0.05) (Figure 2C, 2D).
The possible influential factors
For the 41 studies, the population density was 400-700
people per Km2 (Figure 3A) in 2000, and the population
is predominantly Han Chinese (Figure 3B). Figure 3C
showed that there was no significant correlation between
the geographical latitude and the ratio of female to male
(extracted from China 2000 census) in the population in
the southern and northern latitudes of China. In China,
the annual sunshine duration ranges from less than
1100 hours in parts of Sichuan and Chongqing to over
3400 hours in northwestern Qinghai. The seasonal pat-
terns in sunshine vary considerably by region, but over-
all, the north and the Tibetan Plateau are sunnier than
the south of the country (Figure 3D). But interestingly, for
the annual average temperature and annual relative hu-
midity reported by China Meterological Administration,
its guadually increased from the northern to southern lati-
tudes of China, which maybe possible influential factors
Table 1 Basic information of the 41 studies which met the study validation criteria
No Ref. (First author,
Ref, Year)
Distribution (°) Biopsy-proven LN All biopsy-proven renal diseases




Cases Begin End Sex
(F/M Ratio)
Age (average ± S.D, range)
1 Xu YZ [18] 2009 21.11 110.30 322 19.77 65.04 1627 1999 2007 1.01 30.7 ± 15.1
2 Luo Q [19] 2008 22.35 113.46 76 12.40 60.80 615 2000 2007 1.00 F (33.1 ± 7.8), M (33.56 ± 13.3)
3 Mo WG [20] 2004 22.47 108.20 309 20.61 80.26 5.44 1499 1999 2004 1.07 30.52
4 Zhong HB [21] 2007 26.02 117.36 95 10.41 53.07 913 1993 2006 0.70 30.12 ± 15.37
5 Chen JY [22] 2008 26.02 119.18 31 11.52 62.00 269 1998 2007 0.78 11-68
6 Zhu CL [23] 2003 26.34 106.42 25 25.00 80.65 100 1999 2002 1.70 40.7 ± 28.3
7 Li SR [24] 2004 28.00 119.31 12 10.62 46.15 113 1996 2004 1.05 36, 14-73
8 Ke YJ [25] 2004 28.00 121.20 20 17.70 113 2000 2002 0.61 32.8
9 Xiang XQ [26] 2005 28.12 113.00 87 7.18 1211 1989 2004 35.16 (1989-1997)
35.65 (2000-2004)
10 Sun T [27] 2006 29.33 106.32 46 9.41 54.76 4.75 489 2004 2005 1.39 32 ± 16
11 Shi XD [28] 2003 30.15 119.14 82 12.26 55.78 669 1992 2001 1.42 9-79
12 Xu YC [29] 2005 30.39 104.05 15 11.00 53.57 140 2000 2003 0.94 40.5, 13-70
13 Liu K [30] 2007 31.12 121.29 21 19.63 63.64 107 2003 2005 1.55 32.9
14 Yu JP [31] 2000 31.12 121.29 17 9.60 177 1994 1999 0.86 34.47
15 Chen HP [32] 2000 31.20 118.50 1319 12.45 74.14 10594 1979 2000 0.97 31.4 ± 13
16 Peng YP [33] 2005 31.51 114.52 19 10.80 67.40 176 2000 2004 1.29 38, 13-74
17 Wang T [34] 2010 32.03 118.50 44 5.47 34.92 805 2003 2008 0.98 36.12 ± 16.08
18 Fan YL [35] 1995 33.96 116.23 6 5.66 106 1989 1992 0.58 32, 13-60
19 Du JL [36] 2006 34.15 110.54 220 14.27 53.14 14.7 1542 2000 2004 0.65 33.5 ± 11.8 (LN)
20 Shi J [37] 2010 34.15 110.54 6 2.37 11.76 253 2005 2008 0.85 32 ± 16
21 Wang HX [38] 2007 34.16 117.11 40 11.36 41.70 352 1998 2007 1.10 38 ± 9.5
22 Li SK [39] 2009 34.16 117.11 59 7.94 38.82 4.36 743 2005 2008 0.79 30.09 ± 14.19
23 Wang YT [40] 2010 34.44 113.53 38 4.13 27.74 919 1996 2008 0.81 33.1 ± 14.1, 16-72
24 Zhao ZZ [41] 2005 34.44 113.42 60 14.56 54.55 412 2001 2003 0.98 6-69
25 Li XY [42] 2007 34.44 114.51 9 6.25 28.10 144 1999 2004 1.18 9-72
26 Zhou SY [43] 2008 36.03 103.49 49 4.08 50.00 1202 1994 2006 0.94 31.54
27 Zheng CX [44] 2009 36.63 114.47 33 7.04 31.43 469 2000 2008 0.85 34.6, 9-78
28 Huo J [45] 2007 37.51 112.34 72 5.62 27.20 1281 1993 2006 0.77 31.6 ± 13.3, 6-74
29 Wang YM [46] 2010 38.03 115.28 14 5.22 26.92 268 2004 2009 0.97 35 ± 18, 13-76


















Table 1 Basic information of the 41 studies which met the study validation criteria (Continued)
31 Ding XG [48] 2008 39.36 118.11 21 5.80 37.49 362 2005 2007 0.88 34.3 ± 8.2, 11-70
32 Zhang YP [49] 2001 39.54 116.28 142 7.27 37.10 4.46 1954 1987 1999 0.50 33.2 ± 13, 15–73
33 Wang WX [50] 1996 39.54 116.28 13 12.50 38.24 104 1989 1994 0.51 13-70
34 Liu WX [51] 2008 39.54 116.28 11 11.00 50.00 100 2002 2008 0.82 36.2 ± 14.3, 6-65
35 Hou XY [52] 2009 40.48 111.41 10 4.61 71.43 217 2004 2009 0.75 31.8 ± 10.6, 9-70
36 Wang CH [53] 2009 40.48 116.21 40 15.27 48.78 262 2005 2008 0.76 37.82 ± 15.51, 12-74
37 Li YQ [54] 2006 41.48 123.24 91 7.03 48.37 7.5 1295 1997 2004 0.77 3.62 ± 8.53, 8-76
38 Feng W [55] 2008 43.46 87.36 87 5.80 34.25 1500 1993 2007 0.97 31.4 ± 13, 9-70
39 Yue H [56] 2006 43.46 87.36 12 5.05 41.26 237 1999 2005 0.85 35.6 ± 14, 7-74
40 Wang LY [57] 2005 43.55 125.19 53 10.60 43.09 500 1984 2004 0.66 39.8 ± 3, 7-74
41 Jiang GT [58] 2008 45.45 126.41 61 11.19 64.20 5.8 545 2003 2005 1.27 1.7 ± 12.6, 8-64


















Figure 1 The characteristics of the study centers included in the analyses. The distribution of the studies in China (A), the study period,
from the beginning to the end, for all renal diseases (B), the ratio of the number of females to males in all cases of renal disease (C) and the ratio
of the number of females to males in LN disease (D).
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(Figure 3E, 3F).
Discussion
This study is the first to perform a systematic review of
the literature to investigate the epidemiology of biopsy-
proven lupus nephritis in China. The results showed that
geographical distribution appears to be a risk factor for
the incidence of biopsy-proven LN in China. The pro-
portion of biopsy-proven LN in all biopsy-proven renal
diseases and in the secondary glomerular diseases sig-
nificantly increased with the decreasing geographic lati-
tude from the northern to the southern part of China,
but there was no significant correlation with the change
of geographic longitude. The lack of difference in longi-
tudes may be because most studies located in a particu-
lar longitude band.
A limited amount of data was available regarding
the influence of gender, with only seven studies
[20,27,36,39,54,58] reporting that the ratio of male-to-
female was approximately 1:5 in biopsy-proven LN pa-
tients. As was reported, SLE affects women much more
frequently than men, but there is considerable regional
variation in the ratio of female: male in SLE patients, e.
g., in Curaçao (5:3) [59] in Oman (23:1) [60] and in thePhilippines (23:1) [61]. One of the major target organs in
SLE patients is the kidney, and LN is the most common
types of secondary glomerular diseases and frequently
seen in females [62,63].
There are reports of considerable variation in the ra-
tios of female to male according to different geograph-
ical area of the world, and we investigated whether the
prevalence of biopsy proven-LN is determined by a
higher ratio of females to males in populations living in
the southern latitude compared to the northern latitude
of China. Also, our results showed that there was no sig-
nificant correlation between the geographic latitude and
the ratio of females to males in the populations living in
the southern latitude and the northern latitude in China.
We analyzed the environmental and genetic factor
interaction in the epidemiology of biopsy proven-LN in
China. In the 41 studies, the population density is pre-
dominantly 400-700 people per Km2, and the population
is Han Chinese. So, the population density and ethnicity
may be not decisive factors for the epidemiology of
biopsy proven-LN in China. Another important envir-
onmental factor is the annual duration of sunshine that
ranges from less than 1100 hours in parts of Sichuan and
Chongqing to over 3400 hours in northwestern Qinghai.
Seasonal sunshine patterns vary considerably by region,
Figure 2 The correlation between the geographical distribution and the proportion of biopsy-proven LN. The incidence of LN in all renal
diseases was correlated with the geographic latitude (A), the incidence of LN in secondary glomerular diseases (SGD) correlated with geographic
longitude (B), the incidence of LN in all renal diseases correlated with the geographic latitude (C) and the incidence of LN in secondary
glomerular diseases (SGD) with the geographic longitude (D).
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than the south of China, thus the annual sunshine dur-
ation may be not decisive factors.
Ultraviolet (UV) radiation, a well-recognized induce-
ment of SLE, but UV radiation-measuring networks are
extremely scarce, particularly in China [64]. Also, nu-
merous factors can influence UV radiation, including
cloud characteristics, solar zenith angles, total ozone,
aerosol pollution and surface albedo. Wei et al [65] re-
ported that the summer UV irradiance has increased sig-
nificantly from Central China to the northern and
western parts of China, especially in Central China near
Chongqing, Shanxi, and Hubei provinces; whereas the
UV irradiance has decreased significantly in the south-
ern part of China, especially in South China. In July,
when UV irradiance is at its maximum and hence when
the most serious potential damage may happen, the re-
sults indicate an increase in the UV irradiance in Central
China and the Yangtze River-Huaihe River valley and a
decrease in South China and the eastern part of North
China. Thus the influence of ultraviolet radiation ongeographical distribution of biopsy-proven LN in China
also may be not decisive factors which maybe need to be
further investigated.
However, the annual average temperature and annual
relative humidity reported by China Meterological Ad-
ministration, maybe influential factors on the epide-
miology of biopsy-proven LN in China. According to a
report about the characteristics of seasonal distribution
of active SLE and the influences of meteorological fac-
tors including temperature and humidity on active SLE
in the city of Zhanjiang which is located in the southern-
most continent of China, Liu et al found that active SLE
has the characteristics of seasonal distribution and is as-
sociated with temperature but not related to mean hu-
midity [66].
The majority of LN patients in China receive health
care from a doctor near them, and in the 41 studies,
most of the doctors are affiliated with hospitals of a
medical college or university, well known academic cen-
ters or tertiary referral centers for the local regions. A
limited number of patients travel to specialist centers for
Figure 3 The possible influential factors. Population density of China (A); The distribution of Chinese ethnic groups (B); Ratio of females to
males in different regions of China (C); Average sunshine per year in different regions of China (D); Annual average temperature (E); Annual
relative humidity of China (F).
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gion), Nanjing (in the central region) and Guangzhou (in
the southern region) have among the more renowned
academic centers for LN in China. Some patients are not
treated for glomerular diseases in a few parts of China,
and the criteria for renal biopsy are not identical in dif-
ferent centers. These confounding factors limit the va-
lidity of the conclusions to some degree, and further
studies are needed to provide an accurate estimate of
the absolute risk of geographical distribution related the
epidemiology of LN in China. These important clinical
questions should be addressed by future prospective
studies.Our study is unique in that it involves primarily a
Chinese population. The paper falls within the scope of
lupus, and the observations increase the knowledge of
the epidemiology of biopsy proven-LN in China.
Conclusions
We summarized the data of the 41 studies of LN disease
published in different parts of China and found that geo-
graphical distribution appears to be a risk factor for the
incidence of biopsy-proven LN in China.
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